Mycobacterium tuberculosis (Mtb) can persist in hostile intracellular microenvironments
evading immune cells and drug treatment. However, the protective cellular niches where Mtb …

Combination therapy, a treatment modality that combines two or more therapeutic agents, is
a cornerstone of cancer therapy. The amalgamation of anti-cancer drugs enhances efficacy …

Oral squamous cell carcinoma (OSCC) is the most common malignancy of the head and neck
worldwide. Dysbiosis of the microbiome has increasingly been linked to the development …

Human bone marrow derived mesenchymal stem cells (BM-MSCs) resides in their niches in
close proximity to hematopoietic stem cells (HSCs). These naïve MSCs have tremendous …

Although advances have been made in understanding the role of hypoxia in the stem cell
niche, almost nothing is known about a potentially similar role of hypoxia in maintaining the …

Oral squamous cell carcinoma (OSCC) is the most prevalent malignancy among the Head
and Neck cancer. OSCCs are highly inflammatory, immune-suppressive, and aggressive …

Simple Summary Drug development and therapeutic approaches for treating cancer have
shifted towards incorporating more multimodality approaches that harness the immune system…

Flt1, an “fms-like tyrosine kinase” receptor, has been suggested to play an active role in
vascular endothelial growth factor (VEGF)–mediated autocrine signaling of tumor growth and …

Simple Summary Breast cancer presents a unique clinical problem because of the variety of
cellular subtypes present, including cancer stem cells (CSCs). Breast CSCs can induce the …

… Das), and KaviKrishna Foundation, Assam, India (to B. Das). Additional funding was obtained
from … Das), Stem Cell Altruism Fund, Thoreau Laboratory for Global Health, University of …